Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Paul Moss|Nature Immunology|2021Cited by 420
CMV and Immunosenescence: from basics to clinicsRafael Solana, Graham Pawelec, Sheila Govind et al.|Immunity & Ageing|2012Cited by 182
New advances in CMV and immunosenescencePaolo Sansoni, Janko Nikolich‐Žugich, Rosanna Vescovini et al.|Experimental Gerontology|2014Cited by 149
Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 yearsHelen Parry, Paul Moss|Immunity & Ageing|2016Cited by 126
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Paul Moss|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 80